Neurosurgery and Spine Care: Workforce, Capacity, Access and Outcomes

Summary

This report maps neurosurgery and spine care as a specialty service line. Verified market size and revenue figures are not in the source pack, so the analysis centers on workforce capacity, demand, outcomes and access. US projections show neurosurgery demand outpacing supply: projected supply of 7,230 full-time equivalents against status quo demand of 8,310 ¹. Workforce adequacy is far lower in nonmetropolitan areas, at 30.8% compared with 101% in metropolitan areas ². In one national survey, 64% of neurosurgeons said they plan to leave the workforce within 10 years ³. In spine surgery, higher surgeon volume is associated with lower morbidity and mortality, although the evidence is observational and volume thresholds are undefined ⁶⁷. Key risks are workforce attrition, uneven rural access, weak neurosurgery-specific wait-time data and thin market data. The outlook points to capacity planning, retention and access models as more important than workforce expansion alone ¹⁵.

Key findings

1. 1

   US neurosurgery demand is projected to outpace supply

   Under the status quo scenario, projected demand rises to 8,310 full-time equivalents against a projected supply of 7,230, and national workforce adequacy falls from 100% to 87%. These are projections, not observed outcomes.

   Confidence: Medium
2. 2

   Rural workforce adequacy is far lower than metropolitan adequacy

   Observed adequacy under the status quo scenario was 30.8% in nonmetropolitan areas and 101% in metropolitan areas. Projected inadequacy is greatest in nonmetropolitan areas and in certain states.

   Confidence: High
3. 3

   Retention intentions point to a large near-term attrition risk

   A national survey found 64% of surveyed neurosurgeons plan to leave within 10 years. Career satisfaction, income and patient needs were rated the most important factors for staying. The survey year is not stated in the excerpt.

   Confidence: Medium
4. 4

   Higher surgeon volume is associated with better spine surgery outcomes

   A dose-response meta-analysis found a pooled odds ratio of 0.62 for postoperative morbidity (95% CI 0.52 to 0.75) and 0.76 for mortality (0.66 to 0.87). The studies are observational, and objective proficiency thresholds remain undefined.

   Confidence: Medium
5. 5

   Neurosurgery-specific access and market data are largely missing

   The pack contains no verified neurosurgery wait-time figure, market size, reimbursement data or public, private and community provider comparison. Wait-time evidence found relates to general neurology.

   Confidence: High

1Industry definition and scope

This report treats neurosurgery and spine care as a specialty service line rather than a single market. It covers surgical and related care for conditions of the brain, spine and nervous system, including trauma, stroke-related conditions and spine procedures. Essential neurosurgical care, the scope used in global capacity work, is the reference point for global need ¹⁰.

The geographic scope is global, with US-focused workforce and access evidence. The reporting period is the latest available data. Publication dates in the pack vary, and several study periods are not stated, so changes over time are indicative only.

Terminology differs across sources. One study measures workforce in full-time equivalents ¹, while others use a population-per-surgeon ratio ⁵. Spine activity is counted as procedures in a vendor estimate ¹⁶ and as claims in a metropolitan data set ⁹. The global burden analysis covers neurological conditions broadly ¹¹, which is wider than neurosurgical demand and should not be read as neurosurgery volume.

Segments covered are the neurosurgeon workforce, provider types (neurosurgeons and orthopedic spine surgeons), spine procedure volume, global essential neurosurgery, and neurology referral access as an adjacent pathway. Orthopedic surgeons also perform spine surgery ⁸, so the boundary between the two specialties is part of the analysis.

Scope follows the source pack. Where a source covers neurology rather than neurosurgery, the report says so.

2Market size, structure and value chain

The source pack does not contain a verified global or US neurosurgery and spine care market size, revenue, device spend or reimbursement figure for the reporting period. Market value is therefore not quantified in this report.

The only global procedure volume figure is a vendor estimate: about 5.2 million spine surgery procedures worldwide, under one-quarter of orthopedic procedure volume ¹⁶. The same vendor forecasts about 7.6 million procedures at a 7.9% compound annual rate ¹⁶. This is a vendor claim, and the method behind it is not disclosed in the excerpt, so it should be treated as indicative only.

Stakeholders visible in the pack include neurosurgeons and orthopedic spine surgeons, hospitals whose surgeon volumes affect outcomes ⁶, payers whose plan design relates to wait times ¹², government workforce analysts ¹, and professional societies that survey members ³. The pack does not describe supplier, device manufacturer or payer revenue models.

Within global essential neurosurgical volume, traumatic brain injury and stroke-related conditions make up approximately 60% ¹⁰. The excerpt does not state the period for this figure. The writer's interpretation is that workforce and access capacity, rather than product spend, are the best-supported structural indicators in this pack.

3Customers, demand and adoption

Demand is shaped by the burden of neurological disease. Neurological conditions affected about 3.4 billion people, or 43% of the world population, and caused 443 million disability-adjusted life years, the top contributor to global disease burden ahead of cardiovascular disease ¹¹. These figures cover all neurological conditions, not neurosurgical cases alone.

Unmet need is also significant. An estimated 5 million people each year with treatable neurosurgical conditions never undergo therapeutic surgical intervention ¹⁰. This is an estimate, and the pack does not give a breakdown by country or income level.

In the United States, demand under the status quo scenario is projected to reach 8,310 full-time equivalents ¹. This is a forecast of demand for neurosurgical services, not a measure of realized patient volume.

The pack contains no neurosurgery-specific wait-time figure. For older Medicare patients referred to a neurologist, the average wait was 34 days, and 18% waited more than 90 days ¹³. Seeing a neurologist outside the referral area added an average of 11 days ¹³. These are neurology figures and are used here only as an access signal for the adjacent pathway.

Among commercially insured enrollees, members of consumer driven health plans had estimated waits for new neurology visits about 2.4 days shorter, and estimated stroke waits were about 8.2 days shorter ¹². The excerpt does not establish cause. Digital health adoption rates for neurosurgery or spine care in high-income settings are not verified.

• Neurological conditions affecting the global population 3.4billion people Observed Global, Latest available data [11]
• Disability-adjusted life years from neurological conditions 443million DALYs Observed Global, Latest available data [11]

Global burden figures describe neurological conditions broadly and are not neurosurgery-specific.

4Competitive landscape and key players

Comparable company-level data is limited. The pack contains no market share, revenue or performance data for neurosurgery or spine care companies, so provider types are the main comparison available.

The pack does not verify comparisons of public, private and community neurosurgery capacity or cost per procedure. The regional disparity data groups providers by geography rather than ownership. Adequacy is 101% in metropolitan areas and 30.8% in nonmetropolitan areas ², as summarized below.

Spine neurosurgeons and orthopedic spine surgeons follow different practice patterns. In billing data, spine neurosurgeons had a median of 1,015 new patient office visits per surgeon, while orthopedic spine surgeons performed a higher volume of procedures ⁸. The source describes changing roles in spine surgery. These are billing patterns, not measures of quality.

Higher surgeon volume is linked to better spine outcomes in observational studies ⁶. Competitive pressure may therefore favor high-volume surgeons and centers, but the pack does not verify referral or patient choice behavior. Other systematic reviews report lower complications, shorter stays, lower cost and fewer readmissions with higher volume ⁷, but they note that volume thresholds vary across studies.

Organizations such as the Council of State Neurosurgical Societies ³, the Global Neurosurgery Initiative ¹⁰ and a market research vendor ¹⁶ appear in the pack as evidence producers or market data sources. They are not comparable competitors, and their reports should be read according to their purpose.

The table combines indicators from several studies with different periods and definitions. It is a comparison of indicators, not a ranking of providers.

5Technology, operations and workforce

The US workforce outlook is the central operational indicator in the pack. The neurosurgery workforce is projected to grow slightly, from a baseline of 7,060 full-time equivalents to 7,230, while status quo demand rises to 8,310 ¹. Under the status quo, national adequacy falls from 100% to 87% ¹. These are forecasts, and the excerpt does not state all modeling assumptions.

Retention and age are key workforce pressures. A survey found 64% of neurosurgeons plan to leave within 10 years, and career satisfaction, income and patient needs were rated the most important retention factors ³. Nearly 57% of surveyed neurosurgeons had practiced for more than 20 years ⁴, which raises concern about sustaining patient needs.

Workforce ratios need careful reading. The national neurosurgeon per capita ratio rose slowly over five years and then fell in the most recent three years ⁴. A ratio of 1:65,580 (population per neurosurgeon) was reported in one study ⁵, but its authors note that a shortage signal may reflect factors other than patient need.

Operations and quality are linked to volume. Evidence associates higher surgeon volume with lower complication rates ⁶⁷, but no objective spine surgery proficiency threshold has been verified ⁷. The pack does not include verified data on imaging, robotics or other device adoption.

• Projected US neurosurgery workforce supply 7,230full-time equivalents Forecast United States, Latest projection period [1]
• Neurosurgeons planning to leave the workforce within 10 years 64percent of surveyed neurosurgeons Observed United States, Survey within a 10-year horizon (survey period not stated) [3]

Digital adoption and device technology are not verified for high-income settings, so this section describes workforce and operations evidence only.

6Regulation, standards, risk and sustainability

The pack identifies no binding regulation, clinical standard or payer rule for neurosurgery or spine care in any named jurisdiction. Reimbursement, malpractice cost and spine device pricing data for the reporting period are not verified. Quality and evidence standards in current spine surgery guidelines were also not verified .

This report therefore cannot separate binding requirements from proposed rules or voluntary guidance. Readers should check the relevant national or regional authority for the jurisdiction in which they operate. This analysis is general industry information. It is not medical, legal, investment or engineering advice and does not apply to any individual patient.

Safety risk is tied to case volume. Higher surgeon volume is associated with lower morbidity and mortality in observational meta-analysis ⁶, but studies disagree on volume thresholds ⁷. Policy that relies on a single threshold would need stronger evidence than the pack provides.

Privacy and data use are relevant because several indicators come from claims and billing records ⁹⁸. These are aggregated population indicators in the sources and should not be used to infer individual patient information.

Equity evidence is limited. The pack contains no verified equity outcome data specific to spine surgery. Equity findings relate to neurology wait times ¹²¹³ and to rural workforce gaps ². The neurosurgical community has moved toward addressing factors that drive global disparities ¹⁴. Environmental sustainability is not covered in the pack.

No binding rule, reimbursement schedule or device standard is cited because none appears in the source pack.

7Challenges, opportunities and case examples

The main constraints are workforce shortfall, rural adequacy gaps, surgeon retention and uneven access ¹²³. Workforce expansion alone is insufficient without addressing systemic barriers to entry and retention in neurosurgery ¹⁵. Waiting in neurology referral pathways is also a constraint, although neurosurgery-specific wait times are not verified.

Opportunities include digital applications such as online consultations and remote education, which the source identifies as especially relevant in resource-limited regions of low- and middle-income countries ¹⁵. A shift from surgical missions toward addressing drivers of disparity offers a second route ¹⁴. Volume-based quality findings also support regional capacity planning ⁶.

Case example 1: In the New York City metropolitan area, spine surgery claims fell from 26,066 to 20,437 between the earlier and later periods studied. Volumes later surpassed pre-pandemic levels ⁹. This shows a volume shock and recovery in one metropolitan area, not a national pattern.

Case example 2: The Council of State Neurosurgical Societies survey found 64% of neurosurgeons plan to leave the workforce within 10 years ³. This is an attributable example of how professional societies measure workforce risk.

Case example 3: The Global Neurosurgery Initiative estimates that more than 5 million individuals each year with treatable neurosurgical conditions never undergo therapeutic surgery ¹⁰. It is an estimate that frames the global access gap.

Comparable company examples were limited. The pack contains no company or provider case with verified performance data, so the examples above are organizational and regional data sets.

Examples are chosen from the pack because they are attributable. They are illustrative of evidence types, not of company performance.

8Outlook and strategic implications

In the near term, the most likely pattern supported by the pack is a widening gap between neurosurgery demand and supply under the status quo, with national adequacy projected at 87% ¹. Rural areas face the greatest inadequacy ². This is the writer's interpretation of the projections, not a forecast stated in the sources.

In the medium term, the outcome depends on retention. If the stated intentions of surgeons to leave within 10 years are realized ³, the rural gap and the projected status quo shortfall would persist or grow. If retention improves, adequacy could be closer to projections for supply, but the pack does not quantify that effect.

Key uncertainties include the modeling assumptions behind the projections, the undefined volume thresholds for spine surgery ⁷, the unclear meaning of shortage ratios ⁵, and the absence of neurosurgery-specific wait-time and market data.

Practical implications differ by stakeholder. Hospitals and health systems should plan surgeon capacity and retention, and weigh the observed volume-outcome association ⁶ without assuming a fixed threshold. Payers and public agencies should measure neurosurgery-specific access, since current wait-time evidence is neurology-based ¹³. Digital health developers should focus on resource-limited settings where the evidence is strongest ¹⁵. Researchers should close the data gaps on market size, provider comparisons and reimbursement.

No quantified scenario ranges are given because the pack does not support them.

9Conclusion

Neurosurgery and spine care faces a workforce capacity problem more than a verified market size problem. The strongest evidence points to projected demand growth, a rural adequacy gap, retention risk and volume-linked outcomes. Access and market conclusions remain limited until neurosurgery-specific wait-time, reimbursement and provider comparison data are available.

How this was built

Sources

1. 1

   Neurosurgical workforce projections in the United States: a National Center for Health Workforce Analysis

   Journal of Neurosurgery (citing HRSA National Center for Health Workforce Analysis dashboard) Peer-reviewed

   pubmed.ncbi.nlm.nih.gov
2. 2

   Geographic Disparities in Neurosurgery Workforce Adequacy Across the United States: Projections

   Neurosurgery (peer-reviewed journal, authors per PubMed record) Peer-reviewed

   pubmed.ncbi.nlm.nih.gov
3. 3

   Factors affecting retirement and workforce attrition in neurosurgery: results of a Council of State Neurosurgical Societies national survey

   Journal of Neurosurgery, Council of State Neurosurgical Societies Peer-reviewed

   thejns.org
4. 4

   Trends in the Neurosurgical Workforce and Implications in Providing for an Aging Population

   Mayo Clinic (publication record for journal article) Peer-reviewed

   mayoclinic.elsevierpure.com
5. 5

   Is There a Shortage of Neurosurgeons in the United States?

   Neurosurgery (Rosman, Slane, Dery, Vogelbaum, Cohen-Gadol, Couldwell) Peer-reviewed

6. 6

   Volume-outcome relationships in spine surgery and the surgeon volume meta-analysis

   European Spine Journal systematic review and Neurosurgery and spine dose-response meta-analysis (PubMed records) Peer-reviewed

   pubmed.ncbi.nlm.nih.gov
7. 7

   The impact of surgeon volume on patient outcome in spine surgery: a systematic review

   European Spine Journal (PubMed record) Peer-reviewed

   pubmed.ncbi.nlm.nih.gov
8. 8

   Orthopedics on the Rise: Billing Trends Reveal Changing Roles in Spine Surgery

   PMC (peer-reviewed article) Peer-reviewed

   pmc.ncbi.nlm.nih.gov
9. 9

   Spine surgery volumes during and after COVID-19 in New York City metropolitan area

   Neurosurgical Review (Springer) Peer-reviewed

   link.springer.com
10. 10

    Global neurosurgery: the current capacity and deficit in the provision of essential neurosurgical care

    Journal of Neurosurgery, Global Neurosurgery Initiative at the Program in Global Surgery and Social Change Peer-reviewed

    thejns.org
11. 11

    Neurological conditions now leading cause of ill health and disability globally

    Institute for Health Metrics and Evaluation (IHME), summarizing The Lancet Neurology GBD analysis Official statistics

    healthdata.org
12. 12

    Neurology Wait Times After Primary Care or Emergency Department Visits Among the Commercially Insured Population in the United States

    Neurology (American Academy of Neurology journal) Peer-reviewed

    neurology.org
13. 13

    Wait times for neurology visits: Medicare referral-to-visit analysis (AAN study)

    American Academy of Neurology (via ScienceDaily release) Peer-reviewed

14. 14

    Global neurosurgery overview

    Neurosurgery (Lippincott Williams and Wilkins) Peer-reviewed

    journals.lww.com
15. 15

    Addressing global disparities in neurosurgical workforce and access to care

    Journal of Neurosurgery-related correspondence (PMC, DOI 10.1186/s41016-025-00419-1) Peer-reviewed

    ncbi.nlm.nih.gov
16. 16

    Spine Surgery Global Trends and Opportunities (procedure volume analysis)

    MedGlobalResearch (market research vendor) Market research